Get Task & Purpose in your inbox
A pair of programs currently underway at a Veterans Affairs medical center in Cleveland aim to determine if a low-dose infusion of ketamine — the anesthetic that gained popularity for its street name ‘Special K’ in the 1960s and 70s — can help patients with treatment-resistant depression, and whether the drug can work as an emergency measure to help those at a high risk of suicide.
FAYETTEVILLE, Ark. — Confusion, anger, disappointment and even tears filled an auditorium at the Veterans Health Care System of the Ozarks on Monday as veterans sought answers about a doctor that the hospital alleged last month was working while "impaired."
It’s been a tumultuous week for the Department of Veterans Affairs, after a scathing inspector general report surfaced detailing abuses and errors in VA Secretary David Shulkin’s 10-day trip to Europe last summer. But the fall-out from the investigation hints at a power struggle over the department and its priorities.
The Department of Veterans Affairs will not conduct research into the effects of medical cannabis on post-traumatic stress disorder and chronic pain — some of the very ailments veteran patients rely on the drug to treat.
In 2014, a study by the VA Inspector General found that 20.4% of community-based outpatient clinics run by the Veterans Health Administration failed to provide adequate privacy for female veterans.
Nearly half of all Veterans Health Administration clinicians did not complete suicide risk management training within the timeframe mandated by the Department of Veterans Affairs last year, according to a new report released May 18 by the Department of VA Inspector General.